EXECUTIVE ENGAGEMENTS
POOL
2101
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
378
Interactions with Platform & by Email
PARTICIPANTS
63
Unique # Participated
VALIDATIONS
19
Responses Validated*
COMPANIES
31
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
202
PAGES
268
EDITION
16
PRICE
USD 5600
CODE
MCP-6954
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Metabolomics Market to Reach $5 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Metabolomics estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$5 Billion by 2027, growing at a CAGR of 12.8% over the analysis period 2020-2027. Biomarker Discovery, one of the segments analyzed in the report, is projected to record a 14.3% CAGR and reach US$2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drug Discovery segment is readjusted to a revised 12.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $637.9 Million, While China is Forecast to Grow at 12.2% CAGR
The Metabolomics market in the U.S. is estimated at US$637.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$871.6 Million by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 10.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.
Toxicology Testing Segment to Record 11.5% CAGR
In the global Toxicology Testing segment, USA, Canada, Japan, China and Europe will drive the 11.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$293.6 Million in the year 2020 will reach a projected size of US$623 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
SELECT PLAYERS
AB Sciex LLC; African Biosciences Ltd; Agilent Technologies, Inc.; Agios Pharmaceuticals, Inc.; Berg LLC; BioCat GmbH; Biocenter Finland; Biocrates Life Sciences AG; Biogenetics; Bio-Rad Laboratories, Inc.
SEGMENTS
» Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Other Applications) » End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Metabolomics - The Current Spotlight of "Omics" Toolbox |
| Application Areas |
| Metabolomics in Cancer Detection |
| Growth Drivers |
| Market Barriers & Challenges |
| Recent Market Activity |
| Metabolomics: A Regional Perspective |
| US and Europe Spearhead the Global Metabolomics Market |
| Asia-Pacific: The Fastest Growing Metabolomics Market |
| Biotechnology and Pharmaceutical Sectors Drive Metabolomics Research |
| Demand for Data Analysis Tools and Software on Rise |
| Bioinformatics-based Metabolomics Applications Poised to Grow |
| List of Select Metabolomic Analysis Software |
| Metabolomics in Forensics and PMI Analysis |
| Metabolomics Research Provides New Tools to Understand Human Health |
| Techniques to Examine Metabolites |
| Understanding Human Health and Predicting Disease Risk |
| Causality Assessment |
| NMR-based Metabolomics Screens Desirable LAB Strain with Specific Fermentation Characteristics |
| NMR-based Metabolomics |
| Metabolomics Laboratory Management Systems (LIMS): Growing in Significance |
| Synopsis of Select Metabolomic Databases |
| Some Examples of Metabolomics LIMS |
| Targeted Metabolomics in Newborn Screening: An Area of Success |
| Lack of Standardization - A Prime Concern |
| Metabolomics – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| AB SCIEX (USA) |
| Agilent Technologies, Inc. (USA) |
| Biocrates Life Sciences AG (Austria) |
| Metanomics GmbH (Germany) |
| Bio-Rad Laboratories, Inc. (USA) |
| Bruker Corporation (USA) |
| Chenomx, Inc. (Canada) |
| Human Metabolome Technologies, Inc. (Japan) |
| LECO Corporation (USA) |
| Metabolon, Inc. (USA) |
| Shimadzu Corporation (Japan) |
| SiDMAP, LLC (USA) |
| Thermo Fisher Scientific, Inc. (USA) |
| Waters Corporation (USA) |
| 3. MARKET TRENDS & DRIVERS |
| High Performance Liquid Chromatography (HPLC) Dominates the Market |
| Major Trends in Gas Chromatography: A Quick Review |
| Advances in GC Technology |
| Hyphenated Technologies: Order of the Day |
| Liquid Chromatography Gains Space in Metabolomics Analysis |
| MS Systems with UHPLC: A Novel Fusion |
| HILIC Systems Soaring in Popularity |
| Capillary Electrophoresis Gains Prominence |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Metabolomics Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027 |
| World Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Metabolomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biomarker Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Nutrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Nutrigenomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Functional Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Functional Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Functional Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| JAPAN |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| CHINA |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| EUROPE |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Metabolomics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Metabolomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| FRANCE |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| GERMANY |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Metabolomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Metabolomics by Application - Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Metabolomics by Application - Percentage Breakdown of Value Revenues for Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics and Other Applications for the Years 2012, 2021 & 2027 |
| Rest of World Recent Past, Current & Future Analysis for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Metabolomics by End-Use - Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Metabolomics by End-Use - Percentage Breakdown of Value Revenues for Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End-Uses for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com